DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
R-406
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase SYK inhibitor
R-406
×
Maximum Phase:
2
First Approval:
None
UNII:
RC3A285J2G
Molecule Type:
Small molecule
Molecular Formula:
C22H23FN6O5
Molecular Weight:
470.46
AlogP:
3.63
PSA:
128.75
HBD:
3.0
HBA:
#RotB:
7.0
Source:
SODIUM 2,2-DIMETHYLBUTYRATE
2
Small molecule
Investigational
Unknown
Unknown
Anemia, Sickle Cell; beta-Thalassemia
Unknown
SODIUM 2,2-DIMETHYLBUTYRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
XKM99SPB5I
Molecule Type:
Small molecule
Molecular Formula:
C6H11NaO2
Molecular Weight:
138.14
AlogP:
1.51
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
2.0
Source:
XBD173
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
XBD173
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
R-333
2
Small molecule
Investigational
Unknown
Unknown
Lupus Erythematosus, Systemic
Tyrosine-protein kinase JAK3 inhibitor
R-333
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SITAMAQUINE
2
Small molecule
Investigational
Unknown
Unknown
Leishmaniasis
Unknown
SITAMAQUINE
×
Maximum Phase:
2
First Approval:
None
UNII:
5AIJ4TGC6B
Molecule Type:
Small molecule
Molecular Formula:
C21H33N3O
Molecular Weight:
343.52
AlogP:
4.87
PSA:
37.39
HBD:
1.0
HBA:
#RotB:
11.0
Source:
EMRICASAN
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus; Digestive System Diseases; Liver Diseases; Severe Acute Respiratory Syndrome; Hepatitis, Alcoholic; Hepatitis C, Chronic; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease
Caspase inhibitor
EMRICASAN
×
Maximum Phase:
2
First Approval:
None
UNII:
P0GMS9N47Q
Molecule Type:
Small molecule
Molecular Formula:
C26H27F4N3O7
Molecular Weight:
569.51
AlogP:
2.59
PSA:
150.9
HBD:
4.0
HBA:
#RotB:
10.0
Source:
TOLPERISONE
2
Small molecule
Investigational
Unknown
Unknown
Muscle Spasticity; Arthralgia; Myalgia
Unknown
TOLPERISONE
×
Maximum Phase:
2
First Approval:
None
UNII:
F5EOM0LD8E
Molecule Type:
Small molecule
Molecular Formula:
C16H23NO
Molecular Weight:
245.37
AlogP:
3.3
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
4.0
Source:
MPC-5971
2
Small molecule
Investigational
Unknown
Unknown
Kidney Calculi
Unknown
MPC-5971
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C18H20K2MgO21
Molecular Weight:
674.84
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SAM-760
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SAM-760
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ENRASENTAN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Endothelin receptor ET-A antagonist
ENRASENTAN
×
Maximum Phase:
2
First Approval:
None
UNII:
QG16H8A6ZH
Molecule Type:
Small molecule
Molecular Formula:
C29H30O8
Molecular Weight:
506.55
AlogP:
4.56
PSA:
103.68
HBD:
2.0
HBA:
#RotB:
10.0
Source:
ETARFOLATIDE
2
Small molecule
Investigational
Unknown
Unknown
Ovarian Neoplasms; Adenocarcinoma of Lung; Breast Neoplasms
Unknown
ETARFOLATIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
40UB1H6Q6T
Molecule Type:
Small molecule
Molecular Formula:
C29H34N10O11S
Molecular Weight:
730.72
AlogP:
-2.86
PSA:
337.88
HBD:
11.0
HBA:
#RotB:
19.0
Source:
DOCOSAPENTAENOIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Substance-Related Disorders
Unknown
DOCOSAPENTAENOIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
NS3OZT14QT
Molecule Type:
Small molecule
Molecular Formula:
C22H34O2
Molecular Weight:
330.51
AlogP:
6.77
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
15.0
Source:
GALLIUM
2
Small molecule
Investigational
Unknown
Unknown
Glioblastoma
Unknown
GALLIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
CH46OC8YV4
Molecule Type:
Small molecule
Molecular Formula:
Ga
Molecular Weight:
69.72
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CARICOTAMIDE
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Unknown
CARICOTAMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
MC09H30MFS
Molecule Type:
Small molecule
Molecular Formula:
C8H11N3O2
Molecular Weight:
181.19
AlogP:
-0.94
PSA:
89.42
HBD:
2.0
HBA:
#RotB:
3.0
Source:
VOFOPITANT
2
Small molecule
Investigational
Unknown
Unknown
Bipolar Disorder; Sleep Initiation and Maintenance Disorders; Stress Disorders, Post-Traumatic
Neurokinin 1 receptor antagonist
VOFOPITANT
×
Maximum Phase:
2
First Approval:
None
UNII:
K08BK043YS
Molecule Type:
Small molecule
Molecular Formula:
C21H23F3N6O
Molecular Weight:
432.45
AlogP:
3.27
PSA:
76.89
HBD:
2.0
HBA:
#RotB:
6.0
Source:
BL-1020
2
Small molecule
Investigational
Unknown
Unknown
Psychotic Disorders; Schizophrenia
Unknown
BL-1020
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C25H34Cl2N4O2S
Molecular Weight:
525.55
AlogP:
4.23
PSA:
62.04
HBD:
1.0
HBA:
#RotB:
10.0
Source:
AEE-788
2
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Glioblastoma; Neoplasms
Epidermal growth factor receptor erbB1 inhibitor
AEE-788
×
Maximum Phase:
2
First Approval:
None
UNII:
F9JLR95I3I
Molecule Type:
Small molecule
Molecular Formula:
C27H32N6
Molecular Weight:
440.6
AlogP:
4.94
PSA:
60.08
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TRIACETIN
2
Small molecule
Investigational
Unknown
Unknown
Canavan Disease
Unknown
TRIACETIN
×
Maximum Phase:
2
First Approval:
None
UNII:
XHX3C3X673
Molecule Type:
Small molecule
Molecular Formula:
C9H14O6
Molecular Weight:
218.21
AlogP:
0.04
PSA:
78.9
HBD:
0.0
HBA:
#RotB:
5.0
Source:
TEPILAMIDE FUMARATE
2
Small molecule
Investigational
Unknown
Unknown
Psoriasis
Unknown
TEPILAMIDE FUMARATE
×
Maximum Phase:
2
First Approval:
None
UNII:
KOS9TZ09CM
Molecule Type:
Small molecule
Molecular Formula:
C11H17NO5
Molecular Weight:
243.26
AlogP:
0.13
PSA:
72.91
HBD:
0.0
HBA:
#RotB:
6.0
Source:
IMD-1041
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
IMD-1041
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BAVISANT DIHYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BAVISANT DIHYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
C1H7H5X3RE
Molecule Type:
Small molecule
Molecular Formula:
C19H31Cl2N3O3
Molecular Weight:
420.38
AlogP:
1.44
PSA:
36.02
HBD:
0.0
HBA:
#RotB:
4.0
Source:
SETOGEPRAM
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SETOGEPRAM
×
Maximum Phase:
2
First Approval:
None
UNII:
879OVM0Y1S
Molecule Type:
Small molecule
Molecular Formula:
C13H18O2
Molecular Weight:
206.28
AlogP:
3.05
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
6.0
Source:
TOPIROXOSTAT
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Nephropathies; Hyperuricemia
Xanthine dehydrogenase inhibitor
TOPIROXOSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
0J877412JV
Molecule Type:
Small molecule
Molecular Formula:
C13H8N6
Molecular Weight:
248.25
AlogP:
1.8
PSA:
91.14
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PF-05212377
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Serotonin 6 (5-HT6) receptor antagonist
PF-05212377
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VODOBATINIB
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Dementia; Parkinson Disease
Bcr/Abl fusion protein inhibitor
VODOBATINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
N8Q12KU2SW
Molecule Type:
Small molecule
Molecular Formula:
C27H20ClN3O2
Molecular Weight:
453.93
AlogP:
4.98
PSA:
71.09
HBD:
2.0
HBA:
#RotB:
2.0
Source:
ACLARUBICIN
2
Small molecule
Investigational
Unknown
Unknown
Myelodysplastic Syndromes; Leukemia, Myeloid, Acute; Neoplasms
Unknown
ACLARUBICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
74KXF8I502
Molecule Type:
Small molecule
Molecular Formula:
C42H53NO15
Molecular Weight:
811.88
AlogP:
3.16
PSA:
217.05
HBD:
4.0
HBA:
#RotB:
9.0
Source:
TC-6987
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Diabetes Mellitus, Type 2
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
TC-6987
×
Maximum Phase:
2
First Approval:
None
UNII:
Q2U4R164OG
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DAPANSUTRILE
2
Small molecule
Investigational
Unknown
Unknown
Heart Failure, Systolic; Melanoma; Schnitzler Syndrome; Severe Acute Respiratory Syndrome
NACHT, LRR and PYD domains-containing protein 3 inhibitor
DAPANSUTRILE
×
Maximum Phase:
2
First Approval:
None
UNII:
2Z03364G96
Molecule Type:
Small molecule
Molecular Formula:
C4H7NO2S
Molecular Weight:
133.17
AlogP:
-0.06
PSA:
57.93
HBD:
0.0
HBA:
#RotB:
2.0
Source:
TOREFORANT TARTRATE
2
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Arthritis, Rheumatoid; Asthma; Psoriasis
Unknown
TOREFORANT TARTRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
HSV17TLD9C
Molecule Type:
Small molecule
Molecular Formula:
C50H70N12O6
Molecular Weight:
935.19
AlogP:
4.48
PSA:
69.73
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ORVEPITANT MALEATE
2
Small molecule
Investigational
Unknown
Unknown
Cough
Unknown
ORVEPITANT MALEATE
×
Maximum Phase:
2
First Approval:
None
UNII:
HAX0H28B6W
Molecule Type:
Small molecule
Molecular Formula:
C35H39F7N4O6
Molecular Weight:
744.71
AlogP:
6.8
PSA:
47.1
HBD:
0.0
HBA:
#RotB:
4.0
Source:
AZD-8871
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD-8871
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRAXOPRODIL
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major; Parkinson Disease; Stroke
Glutamate NMDA receptor; GRIN1/GRIN2B antagonist
TRAXOPRODIL
×
Maximum Phase:
2
First Approval:
None
UNII:
UTC046R5HM
Molecule Type:
Small molecule
Molecular Formula:
C20H25NO3
Molecular Weight:
327.42
AlogP:
2.8
PSA:
63.93
HBD:
3.0
HBA:
#RotB:
4.0
Source:
GLPG-0974
2
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Free fatty acid receptor 2 antagonist
GLPG-0974
×
Maximum Phase:
2
First Approval:
None
UNII:
X7REK61AIS
Molecule Type:
Small molecule
Molecular Formula:
C25H25ClN2O4S
Molecular Weight:
485.01
AlogP:
5.05
PSA:
77.92
HBD:
1.0
HBA:
#RotB:
8.0
Source:
C-1311
2
Small molecule
Investigational
Unknown
Unknown
Unknown
DNA topoisomerase II inhibitor
C-1311
×
Maximum Phase:
2
First Approval:
None
UNII:
MZ4Y5H4OAB
Molecule Type:
Small molecule
Molecular Formula:
C20H22N4O2
Molecular Weight:
350.42
AlogP:
2.9
PSA:
69.87
HBD:
2.0
HBA:
#RotB:
6.0
Source:
HEMIN
2
Small molecule
Investigational
Unknown
Unknown
Coproporphyria, Hereditary; Myelodysplastic Syndromes; Pancreatitis; Porphyria, Acute Intermittent; Porphyrias
Unknown
HEMIN
×
Maximum Phase:
2
First Approval:
None
UNII:
743LRP9S7N
Molecule Type:
Small molecule
Molecular Formula:
C34H32ClFeN4O4
Molecular Weight:
651.95
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
1
2
…
99
100
101
102
103
104
105
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA